VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_23-vv-01199
Package ID: USCOURTS-cofc-1_23-vv-01199
Petitioner: Robert Haas
Filed: 2023-07-31
Decided: 2026-06-29
Vaccine: influenza
Vaccination date: 2021-09-03
Condition: Guillain Barré syndrome
Outcome: compensated
Award amount USD: 180000

AI-assisted case summary:
Robert Haas filed a petition on June 2, 2026, alleging that he suffered from Guillain Barré syndrome (GBS) as a result of receiving an influenza vaccine on or about September 3, 2021. He also alleged residual effects lasting more than six months. The respondent denied that the flu vaccine caused GBS or any other injury. Despite maintaining their positions, both parties agreed to settle the case. A stipulation was filed on June 1, 2026, and the court adopted it as its decision. The stipulation awarded Robert Haas a lump sum of $180,000.00 as compensation for all damages.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_23-vv-01199-0
Date issued/filed: 2026-06-29
Pages: 8
Docket text: PUBLIC DECISION (Originally filed: 06/02/2026) regarding 31 DECISION Stipulation/Proffer. Signed by Chief Special Master Brian H. Corcoran. (mva) Service on parties made.
--------------------------------------------------------------------------------
Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 23-1199V
* * * * * * * * * * * * * * * * * * * * * * * * *
*
ROBERT HAAS, * Chief Special Master Corcoran
*
Petitioner, * Filed: June 2, 2026
*
v. *
*
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * *
Leah V. Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for Petitioner.
Austin J. Egan, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On July 31, 2023, Rober Haas filed a petition seeking compensation under the National
Vaccine Injury Compensation Program (the “Vaccine Program”).2 Petitioner alleges that he
suffered from Guillain Barré syndrome (“GBS”) as a result of receiving the influenza (“flu”)
vaccine on or about September 3, 2021. Moreover, Petitioner alleges that he experienced residual
effects of this injury for more than six months.
Respondent denies that Petitioner sustained a GBS Table injury, or that Petitioner’s alleged
GBS was caused by the flu vaccine. Respondent also denies that Petitioner’s receipt of the flu
vaccine caused him any other injury or his current condition. Nonetheless both parties, while
maintaining their above-stated positions, agreed in a stipulation (filed on June 1, 2026) that the
issues before them could be settled, and that a decision should be entered awarding Petitioner
compensation.
1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public
in its present form. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,
100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”).
Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix).

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 2 of 8
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
(as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the
terms set forth therein.
The stipulation awards:
• A lump sum of $180,000.00 to be paid through an ACH deposit to Petitioner’s
counsel’s IOLTA account for prompt disbursement to Petitioner.
Stipulation ¶ 8. This amount represents compensation for all damages that would be available
under Section 15(a) of the Act.
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of
the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
/s/ Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately)
a notice renouncing their right to seek review.

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 3 of 8

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 4 of 8

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 5 of 8

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 6 of 8

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 7 of 8

Case 1:23-vv-01199-UNJ Document 35 Filed 06/29/26 Page 8 of 8